1 - 3 - EPIDEMIOLOGY AND PUBLIC HEALTH IN DERMATOLOGY Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

study of disease in the population, and it includes the incidence, prevalence, distribution, cause, and natural history of disease.

A

Epidemiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

interventional studies that include randomized controlled trials (RCTs

A

Clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

evaluates how an individual receives health care and interacts with the health care system

A

Health services research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most commonly refers to studies of how patients interact with their health care and disease

A

Patient-oriented research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

course of the disease from its onset until its, or the patient’s, end or resolution, the latter of which may be study outcomes of interest

A

natural history of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

measure of how an individual is affected by an illness

A

burden of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

observation of primary interest

A

outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

the strongest association between a risk factor or intervention and an outcome

A

causal association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

application of a substance or an action to subjects in an experimental study

A

intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

attribute that increases the likelihood of developing a disease or other outcome of interest

A

risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

occurs when an attribute or other factor is found to be related to an outcome of interest

A

association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

systematic error that causes the results of a study to deviate from the truth

A

Bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

systematic error in a study caused by how subjects are selected or not selected for a study

A

Selection bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

bias that occurs because of reporting

A

. Information bias i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

occurs when two risk factors or exposures are associated with each other and the outcome of interest

A

Confounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

measure of an effect in an** ideal setting**

A

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Studies that minimize bias are thought to be _______

A

**internally valid, **which means that if the study was repeated using the same study design and the same study cohort, the same results would be found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Studies that measure efficacy are called __________

A

explanatory studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how well an intervention works in the real world

A

Effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Studies that represent results that are reproducible in many other study settings are thought to be _________

A

externally valid or generalizable

21
Q

refers to studies that compare two or more treatments that are generally accepted to be effective

A

Comparative effectiveness

22
Q

often defined based on disease status or having a risk factor of interest

A

cohort

23
Q

subjects receive an active intervention (ie, drug or other treatment)

A

Experimental studies

24
Q

first studies performed in humans and are often designed with the notion that they are human pharmacology studies

A

Phase I studies

25
Q

goal is to evaluate a drug’s dose range, safety, tolerability, pharmacokinetics, and pharmacodynamics

A

Phase I studies

26
Q

also called initial efficacy studies

A

Phase II studies

27
Q

conducted to initially determine the effect of an intervention on patients with the disease of interest

A

Phase II studies

28
Q

also called comparative efficacy studies,

A

Phase III studies

29
Q

designed to assess the efficacy of an intervention compared with that of a “control” treatment (either active treatment or placebo)

A

Phase III studies

30
Q

postmarketing studies

A

Phase IV studies

31
Q

usually conducted after a treatment obtains FDA approval for marketing

A

Phase IV studies

32
Q

They may also be called effectiveness studies because of their focus on how well the approved drug works in the general population and how safe the drug is in a larger population and over a longer period of time

A

Phase IV studies

33
Q

also known as large simple studies or Peto studies, are effectiveness studies that focus on understanding how an intervention works in the routine clinical setting

A

pragmatic trials

34
Q

are those in which subjects are observed and exposures and outcomes are measured in routine care without any effort to intervene or otherwise influence any measured factors

A

Observational studies

35
Q

sometimes called a prospective study,

A

cohort study

36
Q

follows a group of patients over time and monitors the effect of a risk factor or exposure on the development of an outcome

A

cohort study

37
Q

sometimes also called a retrospective study

A

case-control study

38
Q

quantitative study of studies

A

meta-analysis

39
Q

It is a systematic review that attempts to combine the results of multiple studies in order to create a pooled effect estimate of an outcome of interest

A

meta-analysis

40
Q

frequency of a disease or other outcome of interest over a given period of time

A

Prevalence

41
Q

It is measured as the number of individuals with a disease divided by the number of individuals sampled over a specified time period

A

Prevalence

42
Q

frequency of new cases of a disease or other outcome among those who are at risk of the disease or outcome of interest within a specified period of time

A

Incidence

43
Q

refers to those who have the potential to develop the disease or other outcome of interest

A

“at-risk population”

44
Q

typical effect estimate is the

A

risk ratio or relative risk, also called a hazard ratio

45
Q

the ratio of the odds that a case is exposed compared with the odds that a control is exposed

A

odds ratio

46
Q

proportion of truly diseased individuals (ie, true positives and false negatives) who are defined as having the disease by a test (ie, true positives).

A

sensitivity

It is also called the true positive rate

47
Q

the proportion of individuals who truly do not have the disease (ie, false positives and true negatives) who are defined by the test as not having the disease (ie, true negatives).

A

specificity

It is also called the true negative rate

48
Q

proportion of individuals who have a positive test that truly have the disease

A

positive predictive value

49
Q

proportion of individuals who have a negative test who truly do not have the disease

A

negative predictive value